Resistance

(redirected from Antimicrobial resistance)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

Resistance

An effective upper bound on prices achieved because of many willing sellers at that price level.

Resistance Level

In technical analysis, a price that a security does not, or only rarely, rise above. Technical analysts identify a resistance level by looking at past performance. When the security approaches the resistance level, it is seen as an indication to sell the security, which will increase the supply, causing the security's price to fall back below the resistance level. If there are too many buyers, however, the security rises above the resistance level. When this occurs, the price of the security will likely continue to rise until it finds another resistance level. It is also called the overhead resistance level. See also: Price ceiling, Support (Support level).

resistance

An increased supply of a security. Compare support.

Resistance.

Resistance, or resistance level, is the top of a stock's current trading range, and the point at which the price is higher than investors are willing to pay. As stockholders sell at resistance level, the stock price goes down because supply exceeds demand.

For example, if, on a repeated basis, as stock A's price reaches $60, stockholders begin to sell, then $60 is considered its resistance level. But a trading range isn't fixed and investor attitudes change, so the resistance level tends to move higher or lower over time.

If stock A rises to $63 without a surge of selling, the current resistance line has been breached. This may be the result of a rising market or a bullish assessment of the stock's value. On the other hand, if selling increases at $57, that may become the new resistance level.

Conversely, the level at which demand exceeds supply and investors typically buy a certain stock is called support. It's the point that's considered the bottom of a stock's current trading range.

Technical analysts use the concepts of resistance and support in anticipating future stock price movements.

References in periodicals archive ?
He, however, said 'to this effect, FAO has an outlined action plan for 2016-2020 'supporting the food and agriculture sectors in implementing the Global Action Plan on Antimicrobial Resistance to minimize the impact of antimicrobial resistance.'
Antimicrobial resistance. Retrieved from https:// www.who.int/antimicrobial-resistance/en
It is the dire need of time that the Government of Pakistan should initiate national efforts to systematically and successfully deal with the reasons/ causes contributing to antimicrobial resistance in Pakistan.
Antimicrobial resistance is occurring everywhere in the world, compromising our ability to treat infectious diseases, as well as undermining many other advances in health and medicine.
The training is part of a USD 3.3 million project backed by the Russian Federation to help authorities in Armenia, Belarus, Kazakhstan, Kyrgyzstan and Tajikistan get a better handle on the threats posed by antimicrobial resistance in agriculture and food systems.
Conclusion: The awareness related to the causes and spread of antimicrobial resistance came out to be quite low, and the outcomes were found to be associated with gender, age, education, occupation and socioeconomic status.
Consequently, antibiotics have inadvertently facilitated the worldwide increase in antimicrobial resistance. Antimicrobial resistance encompasses the evolution of bacterial defence mechanisms enabling them to escape the effect of antibiotics.
The authors, who worked on the UKAEs Review on Antimicrobial Resistance, which addressed the economic costs of antimicrobial resistance, outline solutions to antimicrobial resistance through a policy and economic lens.
The Global Antimicrobial Resistance Surveillance System Report released by the WHO recently says that resistance to penicillin - the medicine used for decades worldwide to treat pneumonia - ranged from zero to 51 per cent.
A new study has revealed that multinational pharmaceutical companies continue to manufacture dozens of unapproved formulations, despite the global health crisis of rising antimicrobial resistance.
In a global effort to tackle drug resistant superbugs, a project called The Global Burden of Disease AMR (antimicrobial resistance) has been launched.

Full browser ?